Clinical Trial Update: An Open, Randomized, Multicentre, Phase II Pilot Study [Phase 2]

View source ↗

Summary

An open, randomized, multicentre Phase II pilot trial in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Central European Cooperative Oncology Group | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED